We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bicuspid Aortic Valve (BAV) Registry (BAV)

This study is currently recruiting participants.
Verified June 2017 by Dr. Bo Yang, University of Michigan
Sponsor:
ClinicalTrials.gov Identifier:
NCT01756222
First Posted: December 25, 2012
Last Update Posted: June 26, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Dr. Bo Yang, University of Michigan
December 19, 2012
December 25, 2012
June 26, 2017
April 2010
December 2017   (Final data collection date for primary outcome measure)
Characterizing patients with bicuspid aortic valve disease [ Time Frame: 30 years ]
Identifying patients with bicuspid aortic valve disease, assessing the effect of medical intervention.
Same as current
Complete list of historical versions of study NCT01756222 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Bicuspid Aortic Valve (BAV) Registry
Bicuspid Aortic Valve and Ascending Aortic Aneurysm Registry
The purpose of this registry is to gather information on patients with bicuspid aortic valve disease.
The purpose of this registry is to gather information on patients with bicuspid aortic valve disease. The data collected in the registry will be used to assess patterns of aortic dilation, responses to medical therapy based on serial imaging and to assess for potential genetic markers of this disease
Observational [Patient Registry]
Observational Model: Case-Only
Time Perspective: Prospective
30 Years
Retention:   Samples With DNA
Description:
Blood
Non-Probability Sample
Primary clinic
Bicuspid Aortic Valve
Not Provided
Bicuspid Aortic Valve Disease Patients
Patients with the diagnosis of BAV disease.
Not Provided
 
Recruiting
500
December 2017
December 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Any patient over the age of 18 who is able/willing to give informed consent with the diagnosis of bicuspid aortic valve disease, a family history of this disease or an ascending aortic aneurysm that is idiopathic can be included in the registry.

Exclusion Criteria:

  • Patients unable or unwilling to give informed consent.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact: Jennifer L McNamara, MS 734-2324779 jlmcnama@med.umich.edu
United States
 
 
NCT01756222
HUM00035836
Yes
Not Provided
Plan to Share IPD: Undecided
Dr. Bo Yang, University of Michigan
University of Michigan
Not Provided
Principal Investigator: Bo Yang, MD University of Michigan
University of Michigan
June 2017